1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with opc 12759 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (opc 12759) | Trials (opc 12759) | Recent Studies (post-2010) (opc 12759) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 454 | 86 | 230 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, H; Kokura, S; Kondo, M; Naito, Y; Takahashi, S; Takano, H; Tomii, T; Yoshida, N; Yoshikawa, T | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and opc 12759
| Article | Year |
|---|---|
Effects of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats.
Topics: Alanine; Animals; Anti-Ulcer Agents; Gastric Mucosa; Lipid Peroxides; Male; Peroxidase; Platelet Activating Factor; Quinolones; Rats; Rats, Wistar | 1997 |